Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Dipeptidyl peptidase 4 (DPP4) inhibitors improve glycemic control by promoting GLP1-mediated glucose-dependent insulin secretion and suppression of glucagon. Sitagliptin and vildagliptin have been shown to improve insulin sensitivity in patients with type 2 diabetes mellitus (T2DM). Howe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Pharmacol Toxicol
Main Authors: Parthan, Girish, Bhansali, Shobhit, Kurpad, Anura V., Walia, Rama, Bhat, Kishor, Bhansali, Anil
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6030784/
https://ncbi.nlm.nih.gov/pubmed/29970184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-018-0228-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki